The 2010 ADA diagnostic criteria for DM states that a glycated hemoglobin (HbA1c) value ofвЂ‰в‰ҐвЂ‰6.5% is diagnostic of DM if the assay technique is based on high-performance liquid chromatography (HPLC). Plasma glucose 2-h post-glucose load (75В g)вЂ‰в‰ҐвЂ‰11.1В mmol/L According to the 1999 WHO diagnostic criteria, the cut-off plasma glucose values for diagnosing DM are as follows:

Thus, in the work reported in the present paper, we aimed to determine the prevalence of and risk factors for DM in Nigeria using a systematic review and meta-analysis.ДM was diagnosed based on the 1999 WHO diagnostic criteria for DM or the ADA 2010 diagnostic criteria for DM. However, it is important to determine the actual burden of DM in Nigeria to facilitate appropriate health resource allocation, advocacy, and planning. There has been no nationwide health (diabetes) survey in Nigeria since then. The last time a nationwide population estimate of DM was undertaken in Nigeria was during the 1992 Nigerian National Non-communicable Diseases (NCD) survey, where DM was said to occur in 2.2% of the population. Various researchers have reported prevalences ranging from 2% to 12% across the country in recent years. It is widely perceived that prevalence figures reported by the IDF grossly under-report the true burden of DM in Nigeria, given that they are derived through the extrapolation of data from other countries. In Nigeria, the current prevalence of DM among adults aged 20вЂ“69В years is reported to be 1.7%. We now see high rates of DM-related amputations, cerebrovascular disease, heart-related problems, and kidney disease in populations that were not previously known for these challenging health problems.

There is also a rising burden from the complications of DM alongside the ever-increasing prevalence of the disease. The developing economies of Africa and Asia contribute a significant fraction of this figure. The latest prevalence figure published by the International Diabetes Federation (IDF) is 425В million persons living with DM worldwide, with nearly 50% of these undiagnosed. Populations previously unaffected or minimally affected by DM are now reporting soaring prevalence figures, which poses a real challenge to health financing by governments and nongovernmental organizations. This disease has shown a tremendous increase in prevalence with a demographic transition in its epidemiology in recent years. Diabetes mellitus (DM) is a metabolic disorder of chronic hyperglycemia characterized by disturbances to carbohydrate, protein, and fat metabolism resulting from absolute or relative insulin deficiency with dysfunctionВ in organ systems.

Risk pc review